BR112016021296A8 - método para a geração de um aerossol, e usos de imunoglobulina policlonal (ig) - Google Patents
método para a geração de um aerossol, e usos de imunoglobulina policlonal (ig)Info
- Publication number
- BR112016021296A8 BR112016021296A8 BR112016021296A BR112016021296A BR112016021296A8 BR 112016021296 A8 BR112016021296 A8 BR 112016021296A8 BR 112016021296 A BR112016021296 A BR 112016021296A BR 112016021296 A BR112016021296 A BR 112016021296A BR 112016021296 A8 BR112016021296 A8 BR 112016021296A8
- Authority
- BR
- Brazil
- Prior art keywords
- aerosol
- generating
- polyclonal immunoglobulin
- immunoglobulin
- nebulization
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title abstract 3
- 239000000443 aerosol Substances 0.000 title abstract 3
- 102000018358 immunoglobulin Human genes 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000012528 membrane Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000002663 nebulization Methods 0.000 abstract 2
- 239000006199 nebulizer Substances 0.000 abstract 2
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0085—Inhalators using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B17/00—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
- B05B17/04—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
- B05B17/06—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
- B05B17/0607—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
- B05B17/0638—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers spray being produced by discharging the liquid or other fluent material through a plate comprising a plurality of orifices
- B05B17/0646—Vibrating plates, i.e. plates being directly subjected to the vibrations, e.g. having a piezoelectric transducer attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
nebulização de imunoglobulina. a invenção refere-se a métodos para a geração de um aerossol por meio de nebulização de uma composição que compreende imunoglobulina policlonal (ig). a seleção de um nebulizador de membrana eficaz e uma composição otimizada para a nebulização com tal nebulizador de membrana resulta em um método particularmente eficaz para a geração de um aerossol para administração de ig ao trato respiratório.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14163399 | 2014-04-03 | ||
EP14163399.0 | 2014-04-03 | ||
PCT/EP2015/057285 WO2015150510A1 (en) | 2014-04-03 | 2015-04-02 | Nebulization of immunoglobulin |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112016021296A2 BR112016021296A2 (pt) | 2017-08-15 |
BR112016021296A8 true BR112016021296A8 (pt) | 2021-07-20 |
BR112016021296B1 BR112016021296B1 (pt) | 2023-07-18 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
EP3125942A1 (en) | 2017-02-08 |
RU2016142612A3 (pt) | 2018-11-12 |
TWI750108B (zh) | 2021-12-21 |
WO2015150510A1 (en) | 2015-10-08 |
CN106132398A (zh) | 2016-11-16 |
KR20160141832A (ko) | 2016-12-09 |
IL247954A0 (en) | 2016-11-30 |
MX2016012022A (es) | 2017-04-13 |
AU2015239145A1 (en) | 2016-11-17 |
EP3125942B1 (en) | 2021-10-13 |
NZ725681A (en) | 2023-03-31 |
RU2729546C2 (ru) | 2020-08-07 |
CA2943376C (en) | 2022-06-14 |
JP2017511337A (ja) | 2017-04-20 |
KR102337927B1 (ko) | 2021-12-14 |
EP3125942B8 (en) | 2021-12-01 |
ES2902689T3 (es) | 2022-03-29 |
US20170021114A1 (en) | 2017-01-26 |
IL247954B2 (en) | 2023-09-01 |
AU2019246787A1 (en) | 2019-10-31 |
AU2015239145B2 (en) | 2019-07-11 |
JP7256161B2 (ja) | 2023-04-11 |
RU2016142612A (ru) | 2018-05-03 |
SG11201607688YA (en) | 2016-10-28 |
IL247954B1 (en) | 2023-05-01 |
JP2021050210A (ja) | 2021-04-01 |
CA2943376A1 (en) | 2015-10-08 |
CN115177588A (zh) | 2022-10-14 |
DK3125942T3 (da) | 2021-12-20 |
TW201601755A (zh) | 2016-01-16 |
JP7224092B2 (ja) | 2023-02-17 |
BR112016021296A2 (pt) | 2017-08-15 |
US11471617B2 (en) | 2022-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017000285A1 (es) | Terapia combinada para el tratamiento de un paramixovirus | |
EA201790747A1 (ru) | Устройство для генерации аэрозоля | |
EP3405245A4 (en) | HUMIDIFICATION OF RESPIRATORY GASES | |
BR112017001162A2 (pt) | métodos para tratar paramixovírus | |
CL2018000302A1 (es) | Proteínas de fusión de factor ix y métodos para producirlas y utilizarlas | |
NZ725681A (en) | Nebulization of immunoglobulin | |
BR112017002893A2 (pt) | dispositivo e método | |
PE20180260A1 (es) | Metodos y kits para tratar la depresion | |
BR112015022472A2 (pt) | método e sistema para prever a resposta a tratamentos para transtornos mentais | |
CL2016000378A1 (es) | Composiciones y métodos terapéuticos para la regresión acelerada de placa | |
BR112015008203A2 (pt) | método e sistemas para o fornecimento de gás enriquecido de oxigênio. | |
CL2015002608A1 (es) | Compuesto de amino-pirazol y usos medicinales relacionados. | |
CL2014002206A1 (es) | Composición agroquímica en polvo que comprende ácido araquidónico o ácido 9-oxononanoico o una combinación de ambos, y caolín, útil para aumentar tolerancia a estrés abiótico en vegetales. | |
BR112015029462A8 (pt) | Inibidores de quinase | |
CL2016000379A1 (es) | Composiciones y métodos terapéuticos para reducción acelerada de plagas | |
BR112017003164A2 (pt) | composição farmacêutica contendo cineol, método para tratar um paciente que sofre de rinite, uso de uma composição farmacêutica contendo cineol, e aplicador para aplicação intranasal tópica | |
CL2016002754A1 (es) | Dispositivo de tratamiento y procedimiento de tratamiento para el decapado y fosfatado de piezas de metal | |
BR112017012581A2 (pt) | tratamento de degeneração da retina com o uso de células progenitoras | |
BR112019007034A8 (pt) | Método para melhorar o sabor residual de bebidas alcoólicas usando alulose | |
BR112019005040A2 (pt) | aplicação de pridopidina para tratamento de síndrome de rett | |
EP3253434A4 (en) | System for humidification of medical gases | |
MX2016015413A (es) | Carbonato de calcio para medio de impresion de rotograbado. | |
BR112012022090A2 (pt) | utilização de ácido elágico como agente anticaspa | |
BR112018008931A2 (pt) | ?compostos para tratamento de distúrbios hipoproliferativos? | |
CL2016001763A1 (es) | Antagonistas selectivos de nr2b |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/04/2015, OBSERVADAS AS CONDICOES LEGAIS |